Protagonist Therapeutics, Inc (PTGX) Debt Components
- 2020-12-31: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Long-term Debt, Fair ValueUSD $0.00; Debt Instrument, Interest Rate, Stated Percentagepure 7.85%.
- 2020-09-30: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure 7.85%.
- 2020-06-30: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure 7.85%.
- 2020-03-31: Long-term DebtUSD $9.83M; Long-term Debt, GrossUSD $10.00M; Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure 7.85%.
Protagonist Therapeutics, Inc Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-term Debt, Gross USD | Long-term Debt, Fair Value USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Interest Rate, Effective Percentage pure |
|---|---|---|---|---|---|
| 2020-12-31 | (m) | (m) | $0.00 | 7.85% | 9.85% |
| 2020-09-30 | (m) | (m) | (m) | 7.85% | (m) |
| 2020-06-30 | (m) | (m) | (m) | 7.85% | (m) |
| 2020-03-31 | $9.83M | $10.00M | (m) | 7.85% | 9.77% |
| 2019-12-31 | $9.79M | $10.00M | (m) | (m) | 9.81% |
| 2019-12-31 | (m) | (m) | (m) | 7.85% | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |